HIV Vaccines: From Prevention to Cure
Agenda
Prevention Keynote: HIV Vaccine Development: How will we translate scientific opportunity into public health impact?
Human Monoclonal Antibodies for Pre-Exposure Prophylaxis (PrEP) of HIV-1 Infection
Progress in Advancing Vaccine Concepts to P5 Efficacy Trials
Defining Correlates of Protection against HIV/SIV
Ad26 Based Vaccines for HIV and Beyond
Building on Prevention: How prophylactic vaccine trials inform HIV cure
Treatment Keynote: Barriers to a Cure and Therapy: What will a vaccine need to do to be a success?
Planning Committee
Contacts